
    
      Methodology This is a biomedical research, national, multicenter, open-label randomized,
      2-arm phase III superiority trial, comparing neoadjuvant CT with mFolfirinox then
      preoperative CRT, versus immediate preoperative CRT, in patients with locally advanced rectal
      cancer Randomized Phase III study with stopping rules Stratification : center, gender, tumor
      location in the rectum (<6 cm from anal verge versus â‰¥6 cm), initial stage (cT3 vs cT4, and
      cN0 vs cN+)
    
  